comparemela.com

Latest Breaking News On - Samir devani - Page 2 : comparemela.com

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q4 2022 Earnings Call Transcript

Operator: Good morning, and welcome to the BioXcel Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

United-states
Qatar
America
Robyn-karnauskas
Eddie-hickman
Samir-devani
Graig-suvannavejh
Ram-selvaraju
Vince-oneill
Matt-wiley
Sumant-kulkarni
Corinne-jenkins

Valneva SE (NASDAQ:VALN) Q3 2022 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Valneva Reports Nine-Month 2022 Results and Provides Corporate Updates Call. At this time, all participants are in a listen-only mode.

United-kingdom
Sweden
Japan
United-states
Japanese
Peter-buhler
Vivalis-intercell
Samir-devani
Maury-raycroft
Instituto-butantan
Thomas-lingelbach
Pfizer

Covid 19: French drugmaker Valneva in talks with potential partner on second-gen vaccines

French drugmaker Valneva said on Monday it is in talks with a potential partner on producing an updated version of its Covid-19 vaccine that targets new va..

France
French
Samir-devani
Astrazeneca
European-union
Reuters
Covid
Pandemic
Virus
Vaccine

Valneva in talks with potential partner on second-gen C...

PARIS, Sept 26 (Reuters) - French drugmaker Valneva VLS.PA said on Monday it is in talks with a potential partner on producing an updated version of its Covid-19 vaccine that targets new variants of the disease, sending its shares up.

France
French
Sudip-kar-gupta
Darmarah-mackos
Samir-devani
Tassilo-hummel
Astrazeneca
European-union

Valneva in talks with potential partner on second-gen COVID-19 vaccines

PARIS French drugmaker Valneva said on Monday it is in talks with a potential partner on producing an updated version of its COVID-19 vaccine that targets…

Sudip-kar-gupta
Darmarah-mackos
Samir-devani
Tassilo-hummel
European-union

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.